Cargando…

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy

Immune checkpoint inhibitor (ICI) therapy has shown extraordinary promise at treating cancers otherwise resistant to treatment. However, for ICI therapy to be effective, it must overcome the metabolic limitations of the tumor microenvironment. Tumor metabolism has long been understood to be highly d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, Michael F., Cozzo, Alyssa J., Pfeil, Alexander J., Etigunta, Suhas K., Hursting, Stephen D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225951/ https://www.ncbi.nlm.nih.gov/pubmed/32244756 http://dx.doi.org/10.3390/cancers12040852

Ejemplares similares

Dietary Energy Modulation and Autophagy: Exploiting Metabolic Vulnerabilities to Starve Cancer
por: Cozzo, Alyssa J., et al.
Publicado: (2020)

You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis
por: Cozzo, Alyssa J., et al.
Publicado: (2023)

β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma
por: Coleman, Michael F., et al.
Publicado: (2021)

Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
por: Doerstling, Steven S., et al.
Publicado: (2017)

Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
por: Coleman, Michael F., et al.
Publicado: (2021)

Separate and combined effects of advanced age and obesity on mammary adipose inflammation, immunosuppression and tumor progression in mouse models of triple negative breast cancer
por: Smith, Laura A., et al.
Publicado: (2023)

Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
por: Rieth, John, et al.
Publicado: (2018)

Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
por: Chen, Yujia, et al.
Publicado: (2023)

Energy balance, metabolism and cancer prevention: mechanistic insights from transdisciplinary studies
por: Hursting, Stephen D
Publicado: (2012)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020)

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)

Tumor-intrinsic oncogene pathways mediating immune avoidance
por: Spranger, Stefani, et al.
Publicado: (2015)

Competition for nutrients or cell intrinsic programming? – Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer
por: Niu, Yuequn, et al.
Publicado: (2021)

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2021)

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
por: Forlani, Greta, et al.
Publicado: (2023)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis
por: Theivanthiran, Balamayooran, et al.
Publicado: (2021)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

The obesity-breast cancer link: a multidisciplinary perspective
por: Devericks, Emily N., et al.
Publicado: (2022)

Efficacy of the Modified 5-Item Frailty Index in Predicting Surgical-Site Infections in Patients Undergoing Breast Implant Augmentation: A National Surgical Quality Improvement Project-Based 5-Year Study
por: Liu, Helen, et al.
Publicado: (2023)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1
por: Nogueira, Leticia M, et al.
Publicado: (2012)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
por: Devaud, Christel, et al.
Publicado: (2013)

Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
por: Nguyen, Kim Bich, et al.
Publicado: (2019)

MHC-II neoantigens shape tumor immunity and response to immunotherapy
por: Alspach, Elise, et al.
Publicado: (2019)

Modelling the tumor immune microenvironment for precision immunotherapy
por: Mackenzie, Nathan J, et al.
Publicado: (2022)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022)

Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors
por: Hou, Jiakai, et al.
Publicado: (2022)

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
por: Chocarro de Erauso, Luisa, et al.
Publicado: (2020)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling
por: Spranger, Stefani, et al.
Publicado: (2015)

The relationship between autophagy and the immune system and its applications for tumor immunotherapy
por: Jiang, Guan-Min, et al.
Publicado: (2019)

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
por: Sun, Liguang, et al.
Publicado: (2020)

Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

The effects of MYC on tumor immunity and immunotherapy
por: Li, Jiajin, et al.
Publicado: (2023)

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
por: Xu, Liangliang, et al.
Publicado: (2022)

Tumor cell plasticity and intrinsic immunogenicity: Implications for immunotherapy resistance in small‐cell lung cancer
por: Ruan, Ji
Publicado: (2021)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
por: Zheng, Naisheng, et al.
Publicado: (2023)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_regdpqv8he4j83a5rrscbobl47